{"id":"W4321132006","doi":"10.33590/emjdermatol/10314045","title":"Latest Highlights from Guselkumab in Psoriasis from EADV 2019","year":2019,"lang":"en","type":"article","venue":"EMJ Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Tolerability; Clinical trial; Dermatology; Secukinumab; Ustekinumab; Venereology; Internal medicine; Adverse effect; Psoriatic arthritis; Adalimumab; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002776901,0.000793748,0.0008110815,0.0009826958,0.000517562,0.00365645,0.0008470229,0.002942029,0.01172761],"category_scores_gemma":[0.00334935,0.0003387175,0.0009034963,0.0008163296,0.0004605247,0.001929479,0.001332651,0.005630727,0.006445357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001475314,"about_ca_system_score_gemma":0.001534515,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001001415,"about_ca_topic_score_gemma":0.00228125,"domain_scores_codex":[0.9988666,0.0002269621,0.00009263349,0.0001484825,0.0004311082,0.000234236],"domain_scores_gemma":[0.9980196,0.0005340661,0.0001504929,0.00005718346,0.0005562525,0.0006825156],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007190688,0.0001198463,0.0003047647,0.002044743,0.00005574084,0.0005979575,0.00007280439,0.0001376309,0.001679836,0.003112087,0.6970006,0.294155],"study_design_scores_gemma":[0.00009636125,0.0002379598,0.0006556956,0.000661308,0.0000344414,0.0006105891,0.00004227486,0.00004575516,0.0004171889,0.000819421,0.9963671,0.00001193216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002944324,0.7523897,0.0007867208,0.08983845,0.1155438,0.0001052684,0.001138384,0.0001834977,0.03706984],"genre_scores_gemma":[0.02348911,0.5828748,0.001301682,0.09658764,0.2329604,0.0001571962,0.00227548,0.0001755713,0.06017817],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01172761,"threshold_uncertainty_score":0.03923273,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00900181662433231,"score_gpt":0.215701605695829,"score_spread":0.2066997890714967,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}